Literature DB >> 3459150

Identification of proteins that bind tightly to pre-mRNA during in vitro splicing.

S H Mayrand, N Pedersen, T Pederson.   

Abstract

Incubation of a human beta-globin pre-mRNA in a HeLa cell nuclear extract under conditions permissive for efficient splicing resulted in the assembly of the RNA into ribonucleoprotein (RNP) complexes. This RNP formation occurred largely within the characteristic lag period that precedes splicing. Two classes of RNP were detected by the criterion of their stability in Cs2SO4 gradients. One was unstable and contained mainly aberrant RNA cleavage products. The other class of RNP complexes comprised 50-85% of the beta-globin RNA, formed only under splicing-permissive conditions, was stable in Cs2SO4 gradients, and contained both unspliced pre-mRNA molecules and the lariat intron 1-exon 2 splicing intermediate. This latter class of RNP complexes banded at approximately equal to 1.30 g/cm3, a density very similar to that of native heterogeneous nuclear RNP particles that contain pre-mRNA. RNA-protein crosslinking revealed major proteins of Mr approximately equal to 38,000 and 41,000 in the stable class of RNP. The use of antibodies specific for heterogeneous nuclear RNP core proteins and for small nuclear RNA-associated proteins, in conjunction with [32P]RNA-protein crosslinking, revealed polypeptides having the molecular weights of both sets of antigens. These results show that both heterogeneous nuclear RNP particle core proteins and small nuclear RNA-associated proteins bind tightly to pre-mRNA during splicing in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459150      PMCID: PMC323594          DOI: 10.1073/pnas.83.11.3718

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Transcription-dependent localization of U1 and U2 small nuclear ribonucleoproteins at major sites of gene activity in polytene chromosomes.

Authors:  H Sass; T Pederson
Journal:  J Mol Biol       Date:  1984-12-25       Impact factor: 5.469

2.  Identification and characterization of the packaging proteins of core 40S hnRNP particles.

Authors:  A L Beyer; M E Christensen; B W Walker; W M LeStourgeon
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  Characterization of the non-histone nuclear proteins associated with rapidly labeled heterogeneous nuclear RNA.

Authors:  J Karn; G Vidali; L C Boffa; V G Allfrey
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

4.  Some properties of RNA:protein complexes from the nucleus of eukaryotic cells.

Authors:  T Martin; P Billings; A Levey; S Ozarslan; T Quinlan; H Swift; L Urbas
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1974

5.  Proteins associated with heterogeneous nuclear RNA in eukaryotic cells.

Authors:  T Pederson
Journal:  J Mol Biol       Date:  1974-02-25       Impact factor: 5.469

6.  Centrifugation of nuclear ribonucleoprotein particles of sea urchin embryos in cesium sulfate.

Authors:  F H Wilt; M Anderson; E Ekenberg
Journal:  Biochemistry       Date:  1973-02-27       Impact factor: 3.162

7.  Structural organization of nuclear complexes containing DNA-like RNA.

Authors:  O P Samarina; E M Lukanidin; J Molnar; G P Georgiev
Journal:  J Mol Biol       Date:  1968-04-14       Impact factor: 5.469

8.  Nucleoprotein organization of inverted repeat DNA transcripts in heterogeneous nuclear RNA-ribonucleoprotein particles from HeLa cells.

Authors:  J P Calvet; T Pederson
Journal:  J Mol Biol       Date:  1978-07-05       Impact factor: 5.469

9.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  Ultraviolet light-induced crosslinking of mRNA to proteins.

Authors:  J R Greenberg
Journal:  Nucleic Acids Res       Date:  1979-02       Impact factor: 16.971

View more
  9 in total

1.  Purified U5 small nuclear ribonucleoprotein can relieve the inhibition of spliceosome assembly and splicing by snRNP-free nuclear proteins.

Authors:  J Tazi; J Temsamani; C Alibert; W Rhead; S Khellil; G Cathala; C Brunel; P Jeanteur
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  Crosslinking of hnRNP proteins to pre-mRNA requires U1 and U2 snRNPs.

Authors:  S H Mayrand; T Pederson
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

3.  A discrete 3' region of U6 small nuclear RNA modulates the phosphorylation cycle of the C1 heterogeneous nuclear ribonucleoprotein particle protein.

Authors:  S H Mayrand; P A Fung; T Pederson
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

4.  Sequences downstream of AAUAAA signals affect pre-mRNA cleavage and polyadenylation in vitro both directly and indirectly.

Authors:  L C Ryner; Y Takagaki; J L Manley
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  In vitro processing of the human growth hormone primary transcript.

Authors:  K Hartmuth; A Barta
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

6.  Assembly of pre-mRNA splicing complex is cap dependent.

Authors:  E Patzelt; E Thalmann; K Hartmuth; D Blaas; E Kuechler
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

7.  A 62,000 molecular weight spliceosome protein crosslinks to the intron polypyrimidine tract.

Authors:  J Wang; T Pederson
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

8.  Intron sequences and the length of the downstream second exon affect the binding of hnRNP C proteins in an in vitro splicing reaction.

Authors:  P Goswami; C J Goldenberg
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

9.  Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA.

Authors:  M Streuli; H Saito
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.